N/A
Manufactured by Energique, Inc.
16 FDA adverse event reports analyzed
Last updated: 2026-04-15
FERRUM PHOSPHORICUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Energique, Inc.. The most commonly reported adverse reactions for FERRUM PHOSPHORICUM include ABDOMINAL PAIN, ATRIAL FIBRILLATION, CONDITION AGGRAVATED, DIARRHOEA, ECZEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FERRUM PHOSPHORICUM.
Out of 4 classified reports for FERRUM PHOSPHORICUM:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16 FDA FAERS reports that mention FERRUM PHOSPHORICUM. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ABDOMINAL PAIN, ATRIAL FIBRILLATION, CONDITION AGGRAVATED, DIARRHOEA, ECZEMA, EYE PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Energique, Inc. in connection with FERRUM PHOSPHORICUM. Always verify the specific product and NDC with your pharmacist.